001     180150
005     20241220120851.0
024 7 _ |a 10.1002/ijc.34059
|2 doi
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:128805270
|2 altmetric
024 7 _ |a pmid:35499751
|2 pmid
037 _ _ |a DKFZ-2022-01137
082 _ _ |a 610
100 1 _ |a Madi, Alaa Abdelghani Mohamed
|0 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
|b 0
|e First author
|u dkfz
245 _ _ |a CD8 agonism functionally activates memory T cells and enhances antitumor immunity
260 _ _ |a Bognor Regis
|c 2022
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698998092_23208
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D192#LA:D192# / 2022 Sep 1;151(5):797-808 / HI-TRON
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Weisshaar, Nina
|0 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
|b 1
|u dkfz
700 1 _ |a Buettner, Michael
|b 2
700 1 _ |a Poschet, Gernot
|b 3
700 1 _ |a Ma, Sicong
|0 P:(DE-He78)b74df323e3939b563635a2cba7a7afba
|b 4
|u dkfz
700 1 _ |a Wu, Jingxia
|0 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41
|b 5
|u dkfz
700 1 _ |a Mieg, Alessa
|0 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
|b 6
|u dkfz
700 1 _ |a Hering, Marvin
|0 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
|b 7
|u dkfz
700 1 _ |a Ming, Yanan
|0 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d
|b 8
|u dkfz
700 1 _ |a Mohr, Kerstin
|0 P:(DE-He78)6c644df06759d9295db52a00eac44c0f
|b 9
|u dkfz
700 1 _ |a Bosch, Nora
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Cui, Guoliang
|0 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
|b 11
|e Last author
|u dkfz
773 _ _ |a 10.1002/ijc.34059
|g p. ijc.34059
|0 PERI:(DE-600)1474822-8
|n 5
|p 797-808
|t International journal of cancer
|v 151
|y 2022
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:180150
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)b74df323e3939b563635a2cba7a7afba
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)6c644df06759d9295db52a00eac44c0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2021
|d 2022-11-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2021
|d 2022-11-25
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
920 2 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 1 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 0 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D192-20160331
980 _ _ |a UNRESTRICTED
980 _ _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21